Bristol-Myers Squibb (BMY) Stock Insights
BMY$60.57-0.98 -1.59%
$123.73B
Market Cap
13.57
P/E
9.56
Forward P/E
64
Score
Bristol-Myers Squibb (BMY) Stock Insights
BMY price $60.57 -0.98 -1.59%
- Ticker
- BMY
- Price
- $60.57
- Change
- -0.98 -1.59%
- Market cap ?
- $123.73B
- P/E ?
- 13.57
- Forward P/E ?
- 9.56
- Dividend yield ?
- 4.09%
- Beta ?
- 0.23
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stocklytics score
- 64
- Value
- 67
- Quality
- 69
- Growth
- 57
Stocklytics score rationale: value 67, quality 69, growth 57.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 19427000000 | 20776000000 | 22561000000 | 26145000000 | 42518000000 | 46385000000 | 46159000000 | 45006000000 | 48300000000 | 48195000000 |
Bristol-Myers Squibb Company operates as a global biopharmaceutical entity, actively involved in the research, development, licensing, production, and worldwide commercialization of its medicinal portfolio. The company's therapeutic areas span hematology, oncology, cardiovascular health, immunology, fibrotic conditions, neuroscience, and infectious diseases like COVID-19. Its significant pharmaceutical offerings…
Fair value
BMY fair value $134.75. Price $60.57. Price is 55% below fair value.
Below fair value, but more expensive than usual. A smaller discount than on 86% of days in the past 5 years.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 11.44B. Growth 1.09%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 2.04B. Net debt 36.93B. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-10-29 | — | 1.10 | — | 12.72B |
| 2026-07-30 | 2.04 | 1.60 | 12.97B | 11.74B |
| 2026-04-30 | 1.58 | 1.42 | 11.49B | 10.93B |
| 2026-02-05 | 1.26 | 1.23 | 12.50B | 12.28B |
| 2025-10-30 | 1.63 | 1.52 | 12.22B | 11.85B |
| 2025-07-31 | 1.46 | 1.09 | 12.27B | 11.44B |
| 2025-04-24 | 1.80 | 1.49 | 11.20B | 10.70B |
| 2025-02-06 | 1.67 | 1.47 | 12.34B | 11.57B |
| 2024-10-31 | 1.80 | 1.49 | 11.89B | 11.26B |
| 2024-07-26 | 2.07 | 1.62 | 12.20B | 11.54B |
| 2024-04-25 | -4.40 | -4.41 | 11.87B | 11.48B |
| 2024-02-02 | 1.70 | 1.52 | 11.48B | 11.19B |
| 2023-10-26 | 2.00 | 1.76 | 10.97B | 10.97B |
| 2023-07-27 | 1.75 | 1.99 | 11.23B | 11.80B |
| 2023-04-27 | 2.05 | 1.98 | 11.34B | 11.49B |
| 2023-02-02 | 1.82 | 1.71 | 11.41B | 11.19B |
| 2022-10-25 | 1.99 | 1.83 | 11.22B | 11.14B |
| 2022-07-27 | 1.93 | 1.79 | 11.89B | 11.42B |
| 2022-04-29 | 1.96 | 1.92 | 11.65B | 11.36B |
| 2022-02-04 | 1.83 | 1.83 | 11.98B | 12.04B |
| 2021-10-27 | 2.00 | 1.91 | 11.62B | 11.63B |
| 2021-07-28 | 1.93 | 1.88 | 11.70B | 11.61B |
| 2021-04-29 | 1.74 | 1.80 | 11.07B | 11.56B |
| 2021-02-04 | 1.46 | 1.37 | 11.07B | 10.68B |
| 2020-11-05 | 1.63 | 1.49 | 10.54B | 9.63B |
| 2020-08-06 | 1.63 | 1.46 | 10.13B | 9.20B |
| 2020-05-07 | 1.72 | 1.48 | 10.78B | 9.34B |
| 2020-02-06 | 1.22 | 1.30 | 7.95B | 5.73B |
| 2019-10-31 | 1.17 | 1.06 | 6.01B | 5.49B |
| 2019-07-25 | 1.18 | 1.06 | 6.27B | 5.69B |
| 2019-04-25 | 1.10 | 1.09 | 5.92B | 5.87B |
| 2019-01-24 | 0.94 | 0.85 | 5.97B | 5.40B |
| 2018-10-25 | 1.09 | 0.91 | 5.69B | 4.75B |
| 2018-07-26 | 1.01 | 0.87 | 5.70B | 4.91B |
| 2018-04-26 | 0.94 | 0.85 | 5.19B | 4.70B |
| 2018-02-05 | 0.68 | 0.67 | 5.45B | 5.37B |
| 2017-10-26 | 0.75 | 0.77 | 5.25B | 5.39B |
| 2017-07-27 | 0.74 | 0.73 | 5.14B | 5.14B |
| 2017-04-27 | 0.84 | 0.74 | 4.93B | 4.34B |
| 2017-01-26 | 0.63 | 0.67 | 5.24B | 5.58B |
Dividends
Yield 4.16%. Payout ratio 54.89%. Frequency Quarterly.
Safety score 88/100 · Safe. Payout ratio is 55% of earnings. Dividends use a moderate share of free cash flow. Dividends were paid in 55 separate years. Yield is 4.2%, in a range that is usually sustainable.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| 2026-10-02 | $0.63 | 2026-10-02 | 2026-11-02 | Quarterly |
| 2026-07-02 | $0.63 | 2026-07-02 | 2026-08-03 | Quarterly |
| 2026-04-02 | $0.63 | 2026-04-02 | 2026-05-01 | Quarterly |
| 2026-01-02 | $0.63 | 2026-01-02 | 2026-02-02 | Quarterly |
| 2025-10-03 | $0.62 | 2025-10-03 | 2025-11-03 | Quarterly |
| 2025-07-03 | $0.62 | 2025-07-03 | 2025-08-01 | Quarterly |
| 2025-04-04 | $0.62 | 2025-04-04 | 2025-05-01 | Quarterly |
| 2025-01-03 | $0.62 | 2025-01-03 | 2025-02-03 | Quarterly |
| 2024-10-04 | $0.60 | 2024-10-04 | 2024-11-01 | Quarterly |
| 2024-07-05 | $0.60 | 2024-07-05 | 2024-08-01 | Quarterly |
| 2024-04-04 | $0.60 | 2024-04-05 | 2024-05-01 | Quarterly |
| 2024-01-04 | $0.60 | 2024-01-05 | 2024-02-01 | Quarterly |
| 2023-10-05 | $0.57 | 2023-10-06 | 2023-11-01 | Quarterly |
| 2023-07-06 | $0.57 | 2023-07-07 | 2023-08-01 | Quarterly |
| 2023-04-06 | $0.57 | 2023-04-10 | 2023-05-01 | Quarterly |
| 2023-01-05 | $0.57 | 2023-01-06 | 2023-02-01 | Quarterly |
| 2022-10-06 | $0.54 | 2022-10-07 | 2022-11-01 | Quarterly |
| 2022-06-30 | $0.54 | 2022-07-01 | 2022-08-01 | Quarterly |
| 2022-03-31 | $0.54 | 2022-04-01 | 2022-05-02 | Quarterly |
| 2022-01-06 | $0.54 | 2022-01-07 | 2022-02-01 | Quarterly |
| 2021-09-30 | $0.49 | 2021-10-01 | 2021-11-01 | Quarterly |
| 2021-07-01 | $0.49 | 2021-07-02 | 2021-08-02 | Quarterly |
| 2021-03-31 | $0.49 | 2021-04-01 | 2021-05-03 | Quarterly |
| 2020-12-31 | $0.49 | 2021-01-04 | 2021-02-01 | Quarterly |
| 2020-10-01 | $0.45 | 2020-10-02 | 2020-11-02 | Quarterly |
| 2020-07-02 | $0.45 | 2020-07-06 | 2020-08-03 | Quarterly |
| 2020-04-02 | $0.45 | 2020-04-03 | 2020-05-01 | Quarterly |
| 2020-01-02 | $0.45 | 2020-01-03 | 2020-02-03 | Quarterly |
| 2019-10-03 | $0.41 | 2019-10-04 | 2019-11-01 | Quarterly |
| 2019-07-03 | $0.41 | 2019-07-05 | 2019-08-01 | Quarterly |
| 2019-04-04 | $0.41 | 2019-04-05 | 2019-05-01 | Quarterly |
| 2019-01-03 | $0.41 | 2019-01-04 | 2019-02-01 | Quarterly |
| 2018-10-04 | $0.40 | 2018-10-05 | 2018-11-01 | Quarterly |
| 2018-07-05 | $0.40 | 2018-07-06 | 2018-08-01 | Quarterly |
| 2018-04-05 | $0.40 | 2018-04-06 | 2018-05-01 | Quarterly |
| 2018-01-04 | $0.40 | 2018-01-05 | 2018-02-01 | Quarterly |
| 2017-10-05 | $0.39 | 2017-10-06 | 2017-11-01 | Quarterly |
| 2017-07-05 | $0.39 | 2017-07-07 | 2017-08-01 | Quarterly |
| 2017-04-05 | $0.39 | 2017-04-07 | 2017-05-01 | Quarterly |
| 2017-01-04 | $0.39 | 2017-01-06 | 2017-02-01 | Quarterly |
| 2016-10-05 | $0.38 | 2016-10-07 | 2016-11-01 | Quarterly |
| 2016-06-29 | $0.38 | 2016-07-01 | 2016-08-01 | Quarterly |
| 2016-03-30 | $0.38 | 2016-04-01 | 2016-05-02 | Quarterly |
| 2015-12-30 | $0.38 | 2016-01-04 | 2016-02-01 | Quarterly |
| 2015-09-30 | $0.37 | 2015-10-02 | 2015-11-02 | Quarterly |
| 2015-07-01 | $0.37 | 2015-07-06 | 2015-08-03 | Quarterly |
| 2015-04-01 | $0.37 | 2015-04-06 | 2015-05-01 | Quarterly |
| 2014-12-30 | $0.37 | 2015-01-02 | 2015-02-02 | Quarterly |
| 2014-10-01 | $0.36 | 2014-10-03 | 2014-11-03 | Quarterly |
| 2014-07-01 | $0.36 | 2014-07-03 | 2014-08-01 | Quarterly |
| 2014-04-02 | $0.36 | 2014-04-04 | 2014-05-01 | Quarterly |
| 2013-12-31 | $0.36 | 2014-01-03 | 2014-02-03 | Quarterly |
| 2013-10-02 | $0.35 | 2013-10-04 | 2013-11-01 | Quarterly |
| 2013-07-02 | $0.35 | 2013-07-05 | 2013-08-01 | Quarterly |
| 2013-04-03 | $0.35 | 2013-04-05 | 2013-05-01 | Quarterly |
| 2013-01-02 | $0.35 | 2013-01-04 | 2013-02-01 | Quarterly |
| 2012-10-03 | $0.34 | 2012-10-05 | 2012-11-01 | Quarterly |
| 2012-07-03 | $0.34 | 2012-07-06 | 2012-08-01 | Quarterly |
| 2012-04-03 | $0.34 | 2012-04-05 | 2012-05-01 | Quarterly |
| 2012-01-04 | $0.34 | 2012-01-06 | 2012-02-01 | Quarterly |
| 2011-10-06 | $0.33 | 2011-10-11 | 2011-11-01 | Quarterly |
| 2011-06-29 | $0.33 | 2011-07-01 | 2011-08-01 | Quarterly |
| 2011-03-30 | $0.33 | 2011-04-01 | 2011-05-02 | Quarterly |
| 2011-01-05 | $0.33 | 2011-01-07 | 2011-02-01 | Quarterly |
| 2010-09-29 | $0.32 | 2010-10-01 | 2010-11-01 | Quarterly |
| 2010-06-30 | $0.32 | 2010-07-02 | 2010-08-02 | Quarterly |
| 2010-03-30 | $0.32 | 2010-04-04 | 2010-05-03 | Quarterly |
| 2009-12-30 | $0.32 | 2010-01-04 | 2010-02-01 | Quarterly |
| 2009-09-30 | $0.31 | 2009-10-02 | 2009-11-02 | Quarterly |
| 2009-07-01 | $0.31 | 2009-07-06 | 2009-08-03 | Quarterly |
| 2009-04-01 | $0.31 | 2009-04-03 | 2009-05-01 | Quarterly |
| 2008-12-30 | $0.31 | 2009-01-02 | 2009-02-02 | Quarterly |
| 2008-10-01 | $0.31 | 2008-10-03 | 2008-11-03 | Quarterly |
| 2008-07-02 | $0.31 | 2008-07-07 | 2008-08-01 | Quarterly |
| 2008-04-02 | $0.31 | 2008-04-04 | 2008-05-01 | Quarterly |
| 2008-01-02 | $0.31 | 2008-01-04 | 2008-02-01 | Quarterly |
| 2007-10-03 | $0.28 | 2007-10-05 | 2007-11-01 | Quarterly |
| 2007-07-03 | $0.28 | 2007-07-06 | 2007-08-01 | Quarterly |
| 2007-04-03 | $0.28 | 2007-04-06 | 2007-05-01 | Quarterly |
| 2007-01-03 | $0.28 | 2007-01-05 | 2007-02-01 | Quarterly |
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-02 | Gallman Cari | Buy | 4.56K | — | — |
| 2026-10-02 | Gallman Cari | Sell | 2.33K | $61.15 | 142.60K |
| 2026-10-02 | Gallman Cari | Sell | 4.56K | — | — |
| 2026-09-30 | YALE PHYLLIS R | Buy | 561 | $62.40 | 35.00K |
| 2026-09-30 | Samuels Theodore R. II | Buy | 821 | $62.40 | 51.25K |
| 2026-09-30 | Rice Derica W | Buy | 621 | $62.40 | 38.75K |
| 2026-09-30 | McMullen Michael R. | Buy | 561 | $62.40 | 35.00K |
| 2026-09-30 | Arduini Peter J | Buy | 561 | $62.40 | 35.00K |
| 2026-09-09 | Massacesi Cristian | Sell | 6.25K | $64.57 | 403.50K |
| 2026-09-01 | Short Bartie Wendy | Buy | 1.24K | $66.92 | 82.71K |
| 2026-09-01 | Short Bartie Wendy | Sell | 633 | $66.92 | 42.36K |
| 2026-09-01 | Short Bartie Wendy | Sell | 1.24K | $66.92 | 82.71K |
| 2026-08-25 | Holzer Phil M | Sell | 500 | $67.50 | 33.75K |
| 2026-08-01 | Massacesi Cristian | Sell | 51.17K | — | — |
| 2026-08-01 | Massacesi Cristian | Buy | 51.17K | — | — |
| 2026-08-01 | Massacesi Cristian | Sell | 26.18K | $65.31 | 1.71M |
| 2026-08-01 | Gallman Cari | Buy | 1.06K | — | — |
| 2026-08-01 | Gallman Cari | Sell | 543 | $65.31 | 35.46K |
| 2026-08-01 | Gallman Cari | Sell | 1.06K | — | — |
| 2026-06-30 | YALE PHYLLIS R | Buy | 607 | — | — |
| 2026-06-30 | Samuels Theodore R. II | Buy | 889 | — | — |
| 2026-06-30 | Rice Derica W | Buy | 673 | — | — |
| 2026-06-30 | McMullen Michael R. | Buy | 607 | — | — |
| 2026-06-30 | Arduini Peter J | Buy | 607 | — | — |
| 2026-06-15 | Haller Julia A | Buy | 20.46K | $53.76 | 1.10M |
| 2026-06-15 | Haller Julia A | Sell | 20.46K | $53.76 | 1.10M |
| 2026-06-03 | Short Bartie Wendy | Buy | 8.04K | — | — |
| 2026-06-03 | Short Bartie Wendy | Sell | 3.88K | $54.72 | 212.09K |
| 2026-06-03 | Short Bartie Wendy | Sell | 8.04K | — | — |
| 2026-05-01 | Lenkowsky Adam | Buy | 1.37K | — | — |
| 2026-05-01 | Lenkowsky Adam | Sell | 203 | — | — |
| 2026-05-01 | Lenkowsky Adam | Sell | 599 | $58.22 | 34.87K |
| 2026-05-01 | Lenkowsky Adam | Sell | 1.37K | — | — |
| 2026-04-01 | Shanahan Karin | Buy | 3.31K | — | — |
| 2026-04-01 | Shanahan Karin | Sell | 1.69K | $61.73 | 104.45K |
| 2026-04-01 | Shanahan Karin | Sell | 3.31K | — | — |
| 2026-04-01 | Elkins David V | Sell | 25.52K | $61.60 | 1.57M |
| 2026-04-01 | Elkins David V | Sell | 4.48K | $62.05 | 278.05K |
| 2026-03-31 | YALE PHYLLIS R | Buy | 577 | — | — |
| 2026-03-31 | Samuels Theodore R. II | Buy | 845 | — | — |
| 2026-03-31 | Rice Derica W | Buy | 639 | — | — |
| 2026-03-31 | McMullen Michael R. | Buy | 577 | — | — |
| 2026-03-31 | Arduini Peter J | Buy | 577 | — | — |
| 2026-03-10 | Hickey Benjamin | Buy | 17.14K | — | — |
| 2026-03-10 | Hickey Benjamin | Buy | 11.43K | — | — |
| 2026-03-10 | Shibutani Hiroshi Chris | Buy | 11.76K | — | — |
| 2026-03-10 | Shibutani Hiroshi Chris | Buy | 7.84K | — | — |
| 2026-03-10 | Massacesi Cristian | Buy | 39.18K | — | — |
| 2026-03-10 | Massacesi Cristian | Buy | 26.12K | — | — |
| 2026-03-10 | Short Bartie Wendy | Buy | 4.50K | — | — |
| 2026-03-10 | Short Bartie Wendy | Buy | 9.80K | — | — |
| 2026-03-10 | Short Bartie Wendy | Sell | 2.21K | — | — |
| 2026-03-10 | Short Bartie Wendy | Sell | 828 | $60.13 | 49.79K |
| 2026-03-10 | Short Bartie Wendy | Buy | 749 | — | — |
| 2026-03-10 | Short Bartie Wendy | Sell | 81 | — | — |
| 2026-03-10 | Short Bartie Wendy | Buy | 6.53K | — | — |
| 2026-03-10 | Short Bartie Wendy | Sell | 242 | $60.13 | 14.55K |
| 2026-03-10 | Short Bartie Wendy | Buy | 639 | — | — |
| 2026-03-10 | Short Bartie Wendy | Sell | 72 | — | — |
| 2026-03-10 | Short Bartie Wendy | Sell | 205 | $60.13 | 12.33K |
| 2026-03-10 | Short Bartie Wendy | Sell | 749 | — | — |
| 2026-03-10 | Short Bartie Wendy | Sell | 4.50K | — | — |
| 2026-03-10 | Short Bartie Wendy | Sell | 639 | — | — |
| 2026-03-10 | Shanahan Karin | Buy | 19.76K | — | — |
| 2026-03-10 | Shanahan Karin | Buy | 31.84K | — | — |
| 2026-03-10 | Shanahan Karin | Sell | 9.70K | — | — |
| 2026-03-10 | Shanahan Karin | Sell | 5.14K | $60.13 | 309.37K |
| 2026-03-10 | Shanahan Karin | Buy | 21.22K | — | — |
| 2026-03-10 | Shanahan Karin | Buy | 3.29K | — | — |
| 2026-03-10 | Shanahan Karin | Sell | 356 | — | — |
| 2026-03-10 | Shanahan Karin | Sell | 1.50K | $60.13 | 90.38K |
| 2026-03-10 | Shanahan Karin | Buy | 2.45K | — | — |
| 2026-03-10 | Shanahan Karin | Sell | 275 | — | — |
| 2026-03-10 | Shanahan Karin | Sell | 1.11K | $60.13 | 66.86K |
| 2026-03-10 | Shanahan Karin | Sell | 3.29K | — | — |
| 2026-03-10 | Shanahan Karin | Sell | 2.45K | — | — |
| 2026-03-10 | Shanahan Karin | Sell | 19.76K | — | — |
| 2026-03-10 | Plenge Robert M | Buy | 14.05K | — | — |
| 2026-03-10 | Plenge Robert M | Buy | 26.94K | — | — |
| 2026-03-10 | Plenge Robert M | Sell | 6.90K | — | — |
| 2026-03-10 | Plenge Robert M | Sell | 3.17K | $60.13 | 190.73K |
| 2026-03-10 | Plenge Robert M | Buy | 2.34K | — | — |
| 2026-03-10 | Plenge Robert M | Sell | 253 | — | — |
| 2026-03-10 | Plenge Robert M | Buy | 17.96K | — | — |
| 2026-03-10 | Plenge Robert M | Sell | 927 | $60.13 | 55.74K |
| 2026-03-10 | Plenge Robert M | Buy | 1.11K | — | — |
| 2026-03-10 | Plenge Robert M | Sell | 124 | — | — |
| 2026-03-10 | Plenge Robert M | Sell | 436 | $60.13 | 26.22K |
| 2026-03-10 | Plenge Robert M | Sell | 2.34K | — | — |
| 2026-03-10 | Plenge Robert M | Sell | 1.11K | — | — |
| 2026-03-10 | Plenge Robert M | Sell | 14.05K | — | — |
| 2026-03-10 | Meyers Gregory Scott | Buy | 19.76K | — | — |
| 2026-03-10 | Meyers Gregory Scott | Buy | 39.18K | — | — |
| 2026-03-10 | Meyers Gregory Scott | Sell | 9.70K | — | — |
| 2026-03-10 | Meyers Gregory Scott | Sell | 4.27K | $60.13 | 256.57K |
| 2026-03-10 | Meyers Gregory Scott | Buy | 3.29K | — | — |
| 2026-03-10 | Meyers Gregory Scott | Buy | 26.12K | — | — |
| 2026-03-10 | Meyers Gregory Scott | Sell | 356 | — | — |
| 2026-03-10 | Meyers Gregory Scott | Sell | 1.25K | $60.13 | 74.92K |
| 2026-03-10 | Meyers Gregory Scott | Buy | 2.84K | — | — |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 2.62K, holders -27 vs prior quarter. Ownership 85.40%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| BLACKROCK, INC. | 180.38M | 8.70M | +5.07% | 10.39B |
| VANGUARD CAPITAL MANAGEMENT LLC | 133.34M | 1.02M | +0.77% | 7.68B |
| STATE STREET CORP | 102.41M | 3.84M | +3.90% | 5.90B |
| JPMORGAN CHASE & CO | 71.71M | -20.76M | -22.45% | 4.20B |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 67.60M | 6.48M | +10.60% | 3.89B |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 67.60M | 67.60M | New | 3.89B |
| GEODE CAPITAL MANAGEMENT, LLC | 56.44M | 1.16M | +2.09% | 3.24B |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 46.87M | 642.86K | +1.39% | 2.70B |
| NORGES BANK | 36.87M | 36.87M | New | 2.12B |
| BANK OF AMERICA CORP /DE/ | 34.05M | 1.46M | +4.48% | 1.96B |
| PRICE T ROWE ASSOCIATES INC /MD/ | 31.71M | 21.46M | +209.34% | 1.83B |
| MORGAN STANLEY | 29.01M | -189.53K | -0.65% | 1.67B |
| AQR CAPITAL MANAGEMENT LLC | 27.36M | -2.27M | -7.67% | 1.58B |
| AMERIPRISE FINANCIAL INC | 26.67M | 199.35K | +0.75% | 1.54B |
| PRIMECAP MANAGEMENT CO/CA/ | 24.92M | -61.25K | -0.25% | 1.44B |
| NORTHERN TRUST CORP | 24.92M | 159.61K | +0.64% | 1.44B |
| UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC | 22.84M | 119.69K | +0.53% | 1.32B |
| BANK OF NEW YORK MELLON CORP | 21.82M | -1.48M | -6.35% | 1.26B |
| INDEPENDENT FRANCHISE PARTNERS LLP | 21.79M | 517.37K | +2.43% | 1.26B |
| DIMENSIONAL FUND ADVISORS LP | 19.69M | 929.36K | +4.95% | 1.13B |
| LEGAL & GENERAL GROUP PLC | 17.02M | 145.31K | +0.86% | 980.86M |
| GOLDMAN SACHS GROUP INC | 17.02M | 2.96M | +21.08% | 980.51M |
| PZENA INVESTMENT MANAGEMENT LLC | 17.01M | -88.69K | -0.52% | 979.95M |
| FMR LLC | 16.29M | 5.62M | +52.69% | 938.82M |
| INVESCO LTD. | 16.03M | 523.48K | +3.38% | 923.85M |
Insights
- Revenue by product
- Revenue by region
| Period | Value |
|---|---|
| FY2011 | Mature Products And All Other: 2950000000.0 |
| FY2012 | Abilify: 2827000000.0, Baraclude: 1388000000.0, Eliquis: 2000000.0, Erbitux: 702000000.0, Mature Products And All Other: 2756000000.0, Orencia: 1176000000.0, Reyataz: 1521000000.0, Sprycel: 1019000000.0, Sustiva Franchise: 1527000000.0, Yervoy: 706000000.0 |
| FY2013 | Abilify: 2289000000.0, Baraclude: 1527000000.0, Eliquis: 146000000.0, Erbitux: 696000000.0, Mature Products And All Other: 2765000000.0, Orencia: 1444000000.0, Reyataz: 1551000000.0, Sprycel: 1280000000.0, Sustiva Franchise: 1614000000.0, Yervoy: 960000000.0 |
| FY2014 | Abilify: 2020000000.0, Baraclude: 1441000000.0, Diabetes alliance: 295000000.0, Eliquis: 774000000.0, Erbitux: 723000000.0, Hepatitis C Portfolio: 256000000.0, Mature Products And All Other: 3105000000.0, Opdivo: 6000000.0, Orencia: 1652000000.0, Reyataz: 1362000000.0, Sprycel: 1493000000.0, Sustiva Franchise: 1444000000.0, Yervoy: 1308000000.0 |
| FY2015 | Abilify: 746000000.0, Baraclude: 1312000000.0, Eliquis: 1860000000.0, Empliciti: 3000000.0, Erbitux: 501000000.0, Hepatitis C Portfolio: 1603000000.0, Mature Products And All Other: 2571000000.0, Opdivo: 942000000.0, Orencia: 1885000000.0, Reyataz: 1139000000.0, Sprycel: 1620000000.0, Sustiva Franchise: 1252000000.0, Yervoy: 1126000000.0 |
| FY2016 | Abilify: 128000000.0, Baraclude: 1192000000.0, Eliquis: 3343000000.0, Empliciti: 150000000.0, Hepatitis C Portfolio: 1578000000.0, Mature Products And All Other: 2143000000.0, Opdivo: 3774000000.0, Orencia: 2265000000.0, Reyataz: 912000000.0, Sprycel: 1824000000.0, Sustiva Franchise: 1065000000.0, Yervoy: 1053000000.0 |
| FY2017 | Baraclude: 1052000000.0, Eliquis: 4872000000.0, Empliciti: 231000000.0, Hepatitis C Portfolio: 406000000.0, Mature Products And All Other: 2112000000.0, Opdivo: 4948000000.0, Orencia: 2479000000.0, Reyataz: 698000000.0, Sprycel: 2005000000.0, Sustiva Franchise: 729000000.0, Yervoy: 1244000000.0 |
| FY2018 | Baraclude: 744000000.0, Eliquis: 6438000000.0, Empliciti: 247000000.0, Hepatitis C Portfolio: 17000000.0, Mature Products And All Other: 1630000000.0, Opdivo: 6735000000.0, Orencia: 2710000000.0, Reyataz: 427000000.0, Sprycel: 2000000000.0, Sustiva Franchise: 283000000.0, Yervoy: 1330000000.0 |
| FY2019 | Abraxane: 166000000.0, Baraclude: 555000000.0, Eliquis: 7929000000.0, Empliciti: 357000000.0, Mature Products And All Other: 1674000000.0, Opdivo: 7204000000.0, Orencia: 2977000000.0, Pomalyst/Imnovid: 322000000.0, Revlimid: 1299000000.0, Sprycel: 2110000000.0, Yervoy: 1489000000.0 |
| FY2020 | Abraxane: 1247000000.0, Baraclude: 447000000.0, Eliquis: 9168000000.0, Empliciti: 381000000.0, Mature Products And All Other: 1315000000.0, Opdivo: 6992000000.0, Orencia: 3157000000.0, Pomalyst/Imnovid: 3070000000.0, Reblozyl: 274000000.0, Revlimid: 12106000000.0, Sprycel: 2140000000.0, Yervoy: 1682000000.0, Zeposia: 12000000.0 |
| FY2021 | Abecma: 164000000.0, Abraxane: 1181000000.0, Breyanzi: 87000000.0, Eliquis: 10762000000.0, Mature Products And All Other: 1900000000.0, Opdivo: 7523000000.0, Orencia: 3306000000.0, Pomalyst/Imnovid: 3332000000.0, Reblozyl: 551000000.0, Revlimid: 12821000000.0, Sprycel: 2117000000.0, Yervoy: 2026000000.0, Zeposia: 134000000.0 |
| FY2022 | Abecma: 388000000.0, Abraxane: 811000000.0, Breyanzi: 182000000.0, Camzyos: 24000000.0, Eliquis: 11789000000.0, Mature Products And All Other: 1749000000.0, Opdivo: 8249000000.0, Opdualag: 252000000.0, Orencia: 3464000000.0, Pomalyst/Imnovid: 3497000000.0, Reblozyl: 717000000.0, Revlimid: 9978000000.0, Sotyktu: 8000000.0, Sprycel: 2165000000.0, Yervoy: 2131000000.0, Zeposia: 250000000.0 |
| FY2023 | Abecma: 472000000.0, Abraxane: 1004000000.0, Breyanzi: 364000000.0, Camzyos: 231000000.0, Eliquis: 12206000000.0, Opdivo: 9009000000.0, Opdualag: 627000000.0, Orencia: 3601000000.0, Pomalyst/Imnovid: 3441000000.0, Reblozyl: 1008000000.0, Revlimid: 6097000000.0, Sotyktu: 170000000.0, Sprycel: 1930000000.0, Yervoy: 2238000000.0, Zeposia: 434000000.0 |
| FY2024 | Abecma: 406000000.0, Abraxane: 875000000.0, Breyanzi: 747000000.0, Camzyos: 602000000.0, Cobenfy: 10000000.0, Eliquis: 13333000000.0, Krazati: 126000000.0, Opdivo: 9304000000.0, Opdualag: 928000000.0, Orencia: 3682000000.0, Other Growth Brands: 1605000000.0, Other Legacy Brands: 925000000.0, Pomalyst/Imnovid: 3545000000.0, Reblozyl: 1773000000.0, Revlimid: 5773000000.0, Sotyktu: 246000000.0, Sprycel: 1286000000.0, Yervoy: 2530000000.0, Zeposia: 566000000.0 |
| FY2025 | Abecma: 427000000.0, Abraxane: 368000000.0, Breyanzi: 1358000000.0, Camzyos: 1068000000.0, Cobenfy: 155000000.0, Eliquis: 14443000000.0, Krazati: 205000000.0, Opdivo: 10049000000.0, Opdivo Ovantig: 238000000.0, Opdualag: 1185000000.0, Orencia: 3705000000.0, Other Growth Brands: 1924000000.0, Other Legacy Brands: 798000000.0, Pomalyst/Imnovid: 2733000000.0, Reblozyl: 2327000000.0, Revlimid: 2951000000.0, Sotyktu: 291000000.0, Sprycel: 493000000.0, Yervoy: 2900000000.0, Zeposia: 577000000.0 |
| Period | Value |
|---|---|
| FY2010 | Emerging Markets: 804000000.0, Europe: 3448000000.0, Japan, Asia Pacific and Canada: 1651000000.0, Latin America, Middle East and Africa: 856000000.0, Segment, Other: 112000000.0 |
| FY2011 | Emerging Markets: 887000000.0, Europe: 3667000000.0, Other Region: 89000000.0, UNITED STATES: 13845000000.0 |
| FY2012 | Europe: 3706000000.0, Other Region: 327000000.0, Rest Of World: 3204000000.0, UNITED STATES: 10384000000.0 |
| FY2013 | Europe: 3930000000.0, Other Region: 842000000.0, Rest Of World: 3295000000.0, UNITED STATES: 8318000000.0 |
| FY2014 | Europe: 3592000000.0, Other Region: 1112000000.0, Rest Of World: 3459000000.0, UNITED STATES: 7716000000.0 |
| FY2015 | Europe: 3491000000.0, Other Region: 739000000.0, Rest Of World: 4142000000.0, UNITED STATES: 8188000000.0 |
| FY2016 | Europe: 4215000000.0, Other Region: 528000000.0, Rest Of World: 3964000000.0, UNITED STATES: 10720000000.0 |
| FY2017 | Europe: 4988000000.0, Other Region: 553000000.0, Rest Of World: 3877000000.0, UNITED STATES: 11358000000.0 |
| FY2018 | Europe: 5658000000.0, Other Region: 584000000.0, Rest Of World: 3733000000.0, UNITED STATES: 12586000000.0 |
| FY2019 | Europe: 6266000000.0, Other Region: 524000000.0, Rest Of World: 4013000000.0, UNITED STATES: 15342000000.0 |
| FY2020 | Europe: 9853000000.0, Other Region: 631000000.0, Rest Of World: 5457000000.0, UNITED STATES: 26577000000.0 |
| FY2021 | Europe: 10687000000.0, Other Region: 852000000.0, Rest Of World: 5632000000.0, UNITED STATES: 29214000000.0 |
| FY2022 | Europe: 13497000000.0, Other Region: 834000000.0, UNITED STATES: 31828000000.0 |
| FY2023 | Other Region: 699000000.0, Rest Of World: 12752000000.0, UNITED STATES: 31555000000.0 |
| FY2024 | Other Region: 996000000.0, Rest Of World: 13199000000.0, UNITED STATES: 34105000000.0 |
| FY2025 | Other Region: 1087000000.0, UNITED STATES: 33279000000.0 |
Insights · Dividends · Forecast · Financials · Learn